Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-045045
Filing Date
2011-08-09
Accepted
2011-08-09 17:19:37
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 v229027_10q.htm 10-Q 1173406
2 v229027_ex31-1.htm EX-31.1 12092
3 v229027_ex31-2.htm EX-31.2 11637
4 v229027_ex32-1.htm EX-32.1 8610
  Complete submission text file 0001144204-11-045045.txt   3574775

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cbli-20110630.xml EX-101.INS 449643
6 XBRL TAXONOMY EXTENSION SCHEMA cbli-20110630.xsd EX-101.SCH 19479
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbli-20110630_cal.xml EX-101.CAL 40498
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbli-20110630_def.xml EX-101.DEF 83409
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbli-20110630_lab.xml EX-101.LAB 184864
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbli-20110630_pre.xml EX-101.PRE 106808
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

EIN.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 111021896
SIC: 8731 Services-Commercial Physical & Biological Research